Zydus Lifesciences Ltd Share Price

Overview

Zydus Lifesciences Ltd share price is currently ₹1,107.59, up by ₹9.57 (0.87%) from its previous closing price of ₹1,098.02. The share price has gained 0.8% over the past month and gained 13.13% over the past year. The stock's 52-week low and high are ₹826.21 and ₹1,192.41, respectively. Zydus Lifesciences Ltd has a market capitalisation of ₹ 1,10,000.00 Cr. The share price was last updated on 21 Aug 2026, 03:50 PM IST.

Zydus Lifesciences Ltd

ZYDUSLIFE

₹0.00

₹9.57

0.87%

Healthcare

₹0.00(%)1D

Updated: 21 Aug 2026, 03:50:28 pm IST

Market Data

Open Price

₹1,095.24

Prev. Close

₹1,098.02

₹1,086.79

Day Low

₹1,107.59

Day High

₹826.21

52 Week Low

₹1,192.41

52 Week High

HealthcarePharmaceuticals & Drugs

CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

24.65

Sector PE

42.16

PB Ratio

4.11

Sector PB

5.82

EPS

44.94

Dividend Yield

0.11

Today's Volume

1.005 M

5 Day Avg. Volume

1.196 M

PEG Ratio

2.17

Market Cap.

₹ 1,10,000.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 100% at ₹1/Share	24-Jul-2026	24-Jul-2026
DividendsFinal Dividend of 1100% at ₹11/Share	25-Jul-2025	25-Jul-2025

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Parag Parikh Flexi Cap Fund - Regular Plan - Growth	1.93 Cr	1.93 Cr no change
Kotak Flexicap Fund - Growth	1.04 Cr	1.04 Cr no change
ICICI Prudential Large Cap Fund - Growth	28.03 Lac	28.03 Lac no change
Bandhan Large & Mid Cap Fund - Regular Plan - Growth	10.47 Lac	18.41 Lac (75.8%)
HSBC Midcap Fund - Regular Plan - Growth	-	16.35 Lac (100%)

Show all holdings

About Zydus Lifesciences Ltd 👋

Zydus Lifesciences Limited is an India-based life-sciences company with positions across pharmaceuticals and consumer wellness, supported by a MedTech franchise and a global footprint across United States, India and other international markets. Its pharmaceutical business includes integrated pharmaceutical operations with business encompassing the entire value chain in research, development, production, marketing and distribution of pharmaceutical products. Its product portfolio includes active pharmaceutical ingredients, human formulations, and animal health and veterinary. Its consumer products business includes development, production, marketing and distribution of differentiated health and wellness products. It provides biologicals manufacturing sites offering contract development and manufacturing organization services to biopharmaceutical companies globally. Its focused therapy areas include cardiology, anti-diabetes, super specialty areas of oncology and nephrology, and others.